The European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) brings together 53 organisations from 30 countries in EU and beyond, providing joint support to research and innovation and mobilising to address the challenges of antimicrobial resistance (AMR) with a One Health approach.
Antimicrobial resistance (AMR) is a global health challenge that affects human and animal health, food security and the environment. Immediate action is needed to boost AMR research and innovation (R&I) to better understand the biological mechanisms of resistance and evolution in microorganisms, as well as how AMR spreads, including social and human factors. There is a need for R&I to develop new treatments for infections and rapid and affordable diagnostics, and to improve current treatment solutions. New knowledge is also needed to improve surveillance methods and design innovative interventions to prevent and mitigate AMR.
Delivering R&I on this scale, and for impact, requires a collaborative and sustainable research community where capacities and assets are shared and used efficiently. Moreover, new knowledge must be implemented across many parts of the society to facilitate the translation and uptake of innovative solutions in real-word settings. Engagement from for example professional groups, civil society and regulators will be necessary to achieve sustainable change and impact.
Our Vision and Mission
Vision: To reduce the burden of antimicrobial resistance.
Mission: To boost One Health research and innovation leading to improved surveillance of resistant pathogens, better diagnostics and effective treatment of infections and to prevention measures reducing the use of antimicrobials and the spread of antimicrobial resistance.
The formation of the European Partnership One Health Antimicrobial Resistance (EUP OHAMR) was proposed by the European Commission within the framework of the Horizon Europe work programme 2023/2024, to align R&I funding and other activities among the EU countries and beyond. The partnership builds on the legacy of the Join Programming Initiative on Antimicrobial Resistance (JPIAMR), which has invested over 180 million Euro for research projects and networks between 2011 and 2024.
The EUP OHAMR brings together 53 organisations from 30 countries across EU and beyond, aiming to close knowledge gaps and break silos between sectors, disciplines and perspectives. As a global collaboration of organisations across society, the EUP OHAMR is expected to contribute towards the European One Health Action Plan against AMR and the Global Sustainable Development Goals (see links below).
The EUP OHAMR deploys an integrated One Health approach, recognising that human, animal and plant health are interdependent and interlinked with the environment.
The EUP OHAMR in brief
- Consortium of 53 organisations across 30 countries
- 10 year programme 2025-2035
- Ambitious framework of programmes consisting of funding for R&I projects, capacity strengthening, knowledge translation, data exploitation and impact
- Approx. €250 million pooled funding for R&I projects
- Co-funded by the EU with up to €75 million towards the implementation of the programme and support for R&I projects
- Coordinated by the Swedish Research Council, Sweden
Implementation programmes
The activities of the EUP OHAMR will be organised within four programmes.
SRIA
The scientific priorities and direction of the EUP OHAMR are described in our Strategic Research and Innovation Agenda.
JPIAMR (jpiamr.eu)
Link to another websiteThe partnership builds on the legacy of the Joint Programming Initiative on Antimicrobial Resistance, JPIAMR.